- $21.08bn
- $22.56bn
- $12.14bn
- 72
- 57
- 93
- 86
R2019 December 31st | R2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-Q | 10-Q | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Net Total Receivables | 424 | 525 | — | 234 | 304 |
Net Property, Plant And Equipment | 615 | 406 | 420 | 593 | 603 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Insurance Receivables | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Deferred Policy Acquisition Costs | |||||
Total Other Assets | |||||
Total Assets | 26,662 | 28,572 | 32,048 | 33,861 | 37,202 |
Accrued Expenses | |||||
Policy Liabilities | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 20,587 | 22,261 | 25,395 | 27,113 | 29,747 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 6,075 | 6,311 | 6,653 | 6,748 | 7,455 |
Total Liabilities & Shareholders' Equity | 26,662 | 28,572 | 32,048 | 33,861 | 37,202 |
Total Common Shares Outstanding |